The COVID-19 outbreak has affected
almost every facet of life which is why there is a section below on facts, forms, and other
sources of information that you can review to help you understand Avellino’s response to
High performance for high confidence, proven in over 75,000 patients.
The COVID-19 outbreak has been fast and severe, first affecting the Avellino teams and facilities in
China and South Korea.
Avellino is an early-stage, genetic-testing and personalized medicine company that did not have the
resources to halt commercial sales and start producing the company’s novel AvellinoCoV2 test.
A comprehensive solution for returning to work
Contact Avellino for information on genetic counseling and learn how you can utilize the network to support
your patients who need further explanation of their at-risk or positive results.